IMBRUVICA (ibrutinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·CHRONIC LYMPHOCYTIC LEUKEMIA·+5
PHARMACYCLICS,
Indication
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes. Read more about Chronic lymphocytic leukemia
23 drugs 15 manufacturers
Drugs that treat it
Common Chronic lymphocytic leukemia therapies.
COPIKTRA (duvelisib)
ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIB.·CHRONIC LYMPHOCYTIC LEUKEMIA·+1
VERASTEM, INC.
TRUXIMA (rituximab-abbs)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+7
CEPHALON,INC.
BRUKINSA (zanubrutinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·CHRONIC LYMPHOCYTIC LEUKEMIA·+5
BEONE MEDICINES
RUXIENCE (rituximab-pvvr)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+7
Parke-Davis Pfizer
RIABNI (rituximab-arrx)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+9
AMGEN
BREYANZI (lisocabtagene maraleucel)
CHRONIC LYMPHOCYTIC LEUKEMIA·+6
JUNO THERAPEUTI
COPIKTRA (duvelisib)
ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIB.·CHRONIC LYMPHOCYTIC LEUKEMIA·+1
SECURA BIO, INC
BREYANZI (lisocabtagene maraleucel)
ANTINEOPLASTIC - CAR-T/TCR-T CELL IMMUNOTHERAPY·CHRONIC LYMPHOCYTIC LEUKEMIA·+6
JUNO/BMS COMPAN
Filter & compare in the drug finder →Opens the drug finder with Chronic lymphocytic leukemia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes.
Primarily affecting older adults, it involves the peripheral blood, bone marrow, spleen, and lymphoid tissues.
Defining clinical and pathophysiologic features include sustained peripheral absolute lymphocytosis, progressive bone marrow infiltration leading to cytopenias, painless lymphadenopathy, hepatosplenomegaly, and increased susceptibility to infections secondary to impaired immune function.
- nih.gov
Chronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes Primarily affecting older adults, it involves the peripheral blood, bone marrow, spleen, and lymphoid tissues Defining clinical and pathophysiologic features include sustained peripheral absolute lymphocytosis, progressive bone marrow infiltration leading to cytopenias, painles...
- nih.gov
Chronic lymphocytic leukemia is an indolent hematologic malignancy characterized by the progressive clonal proliferation and accumulation of morphologically mature, immunologically dysfunctional CD5-positive B lymphocytes Defining clinical and pathophysiologic features include sustained peripheral absolute lymphocytosis, progressive bone marrow infiltration leading to cytopenias, painless lymphadenopathy, hepatosplenomegaly, and increased susceptibility to infections secondary to impaired immune...
- nih.gov
Primarily affecting older adults, it involves the peripheral blood, bone marrow, spleen, and lymphoid tissues
Personalize your experience
Follow Chronic lymphocytic leukemia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.